Reply: Diagnostic accuracy of AGILE3+ score for advanced fibrosis in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis-Reference-Cited by-同舟云学术

Reply: Diagnostic accuracy of AGILE3+ score for advanced fibrosis in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis

Published:2023-12-13 Issue: Volume: Page:
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:

Author:

Dalbeni Andrea¹²^ORCID,Mantovani Alessandro³^ORCID,Lombardi Rosa⁴^ORCID,Ravaioli Federico⁵⁶^ORCID

Affiliation:

1. Section of General Medicine C, Azienda Ospedaliera Universitaria Integrata of Verona, Verona, Italy

2. Liver Unit, University and Azienda Ospedaliera Universitaria Integrata of Verona, Verona, Italy

3. Section of Endocrinology, Diabetes and Metabolism, University and Azienda Ospedaliera Universitaria Integrata of Verona, Verona, Italy

4. SC-Medicina Indirizzo Metabolico, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico of Milan, Department of Pathophysiology and Transplantation , University of Milan, Milan, Italy

5. Division of Internal Medicine, Hepatobiliary and Immunoallergic Diseases, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Italy

6. Department of Medical and Surgical Sciences (DIMEC), University of Bologna, Bologna, Italy

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Hepatology

Reference3 articles.

1. Diagnostic accuracy of AGILE3+ score for advanced fibrosis in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis;Dalbeni;Hepatology,2023

2. N-terminal propeptide of type 3 collagen-based sequential algorithm can identify high-risk steatohepatitis and fibrosis in MAFLD;Tang;Hepatol Int,2023

3. Increased accuracy in identifying NAFLD with advanced fibrosis and cirrhosis: Independent validation of the Agile 3+ and 4 scores;Noureddin;Hepatol Commun,2023